These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38156601)

  • 1. Process Evaluation of a Double-Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension Within a Federally Qualified Health Center Network (QUARTET USA).
    Sanuade OA; Jacobson TA; Quintana A; Flowers FM; Abbasi H; Vu MH; Baldridge AS; Mejia J; Lazar D; Ciolino JD; Huffman MD; Kandula NR
    J Am Heart Assoc; 2024 Jan; 13(1):e032236. PubMed ID: 38156601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA): Rationale and design for a randomized controlled trial.
    Baldridge AS; Huffman MD; Lazar D; Abbas H; Flowers FM; Quintana A; Jackson A; Khan SS; Chopra A; Vu M; Tripathi P; Jacobson T; Sanuade OA; Kandula NR; Persell SD; Paparello JJ; Rosul LL; Mejia J; Lloyd-Jones DM; Chow CK; Ciolino JD
    Am Heart J; 2022 Dec; 254():183-193. PubMed ID: 36116516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
    Chow CK; Atkins ER; Hillis GS; Nelson MR; Reid CM; Schlaich MP; Hay P; Rogers K; Billot L; Burke M; Chalmers J; Neal B; Patel A; Usherwood T; Webster R; Rodgers A;
    Lancet; 2021 Sep; 398(10305):1043-1052. PubMed ID: 34469767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol.
    Chow CK; Atkins ER; Billot L; Chalmers J; Hillis GS; Hay P; Neal B; Nelson M; Patel A; Reid CM; Schlaich M; Usherwood T; Webster R; Rodgers A
    Am Heart J; 2021 Jan; 231():56-67. PubMed ID: 33017580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participants' views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial.
    Kovoor JG; Chow CK; Salam A; Webster R; Shiel L; Nelson MR; Affandi JS; Hay P; Burke M; Figtree GA; Usherwood T; Reid CM; Schlaich MP; Rodgers A; Atkins ER
    J Hum Hypertens; 2024 Jun; 38(6):516-522. PubMed ID: 38744907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a Coordinated Community and Chronic Care Model Team Intervention vs Usual Care on Systolic Blood Pressure in Patients With Stroke or Transient Ischemic Attack: The SUCCEED Randomized Clinical Trial.
    Towfighi A; Cheng EM; Ayala-Rivera M; Barry F; McCreath H; Ganz DA; Lee ML; Sanossian N; Mehta B; Dutta T; Razmara A; Bryg R; Song SS; Willis P; Wu S; Ramirez M; Richards A; Jackson N; Wacksman J; Mittman B; Tran J; Johnson RR; Ediss C; Sivers-Teixeira T; Shaby B; Montoya AL; Corrales M; Mojarro-Huang E; Castro M; Gomez P; Muñoz C; Garcia D; Moreno L; Fernandez M; Lopez E; Valdez S; Haber HR; Hill VA; Rao NM; Martinez B; Hudson L; Valle NP; Vickrey BG;
    JAMA Netw Open; 2021 Feb; 4(2):e2036227. PubMed ID: 33587132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): statistical analysis plan for a randomized, blinded, crossover trial.
    Zhao X; Li X; Liu T; Yang G; Chen Y; Huang M; Zhao L; Li X; Jiang W
    Trials; 2024 Jan; 25(1):45. PubMed ID: 38218924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review.
    Chow CK; Thakkar J; Bennett A; Hillis G; Burke M; Usherwood T; Vo K; Rogers K; Atkins E; Webster R; Chou M; Dehbi HM; Salam A; Patel A; Neal B; Peiris D; Krum H; Chalmers J; Nelson M; Reid CM; Woodward M; Hilmer S; Thom S; Rodgers A
    Lancet; 2017 Mar; 389(10073):1035-1042. PubMed ID: 28190578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical Trial.
    Daugherty SL; Helmkamp L; Vupputuri S; Hanratty R; Steiner JF; Blair IV; Dickinson LM; Maertens JA; Havranek EP
    JAMA Netw Open; 2021 Dec; 4(12):e2139533. PubMed ID: 34913976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial treatment with a single capsule containing half-dose quadruple therapy vs standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
    Zhao X; Chen Y; Yang G; Li X; Tang X; Yang Q; Peng L; Li J; Liang Z; Li A; Wang W; Huang M; Liu T; Li X; Jiang W
    Am Heart J; 2023 Oct; 264():10-19. PubMed ID: 37276913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial.
    Webster R; Salam A; de Silva HA; Selak V; Stepien S; Rajapakse S; Amarasekara S; Amarasena N; Billot L; de Silva AP; Fernando M; Guggilla R; Jan S; Jayawardena J; Maulik PK; Mendis S; Mendis S; Munasinghe J; Naik N; Prabhakaran D; Ranasinghe G; Thom S; Tisserra N; Senaratne V; Wijekoon S; Wijeyasingam S; Rodgers A; Patel A;
    JAMA; 2018 Aug; 320(6):566-579. PubMed ID: 30120478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial.
    Haramiova Z; Stasko M; Hulin M; Tesar T; Kuzelova M; Morisky DM
    Trials; 2017 Jul; 18(1):334. PubMed ID: 28720121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial.
    Wang N; Von Huben A; Marschner S; Nelson MR; Nolde JM; Schlaich MP; Figtree G; Hillis GS; Usherwood T; Reid CM; Chalmers J; Jansen S; Atkins ER; Billot L; Chow C; Rodgers A;
    Hypertension; 2024 May; 81(5):1087-1094. PubMed ID: 38477128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
    Chrysant SG; Littlejohn T; Izzo JL; Kereiakes DJ; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Am J Cardiovasc Drugs; 2012 Aug; 12(4):233-43. PubMed ID: 22799613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET Study.
    Nolde JM; Atkins E; Marschner S; Hillis GS; Chalmers J; Billot L; Nelson MR; Reid CM; Hay P; Burke M; Jansen S; Usherwood T; Rodgers A; Chow CK; Schlaich MP
    Circulation; 2023 Jul; 148(4):375-377. PubMed ID: 37486996
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial.
    Hong SJ; Jeong HS; Cho JM; Chang K; Pyun WB; Ahn Y; Hyon MS; Kang WC; Lee JH; Kim HS
    Clin Ther; 2019 Feb; 41(2):233-248.e9. PubMed ID: 30665829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical Trial.
    Na SH; Lee HY; Hong Baek S; Jeon HK; Kang JH; Kim YN; Park CG; Ryu JK; Rhee MY; Kim MH; Hong TJ; Choi DJ; Cho SW; Cha DH; Jeon ES; Kim JJ; Shin JH; Park SH; Lee SH; John SH; Shin ES; Kim NH; Lee SY; Kwan J; Jeong MH; Kim SW; Jeong JO; Kim DW; Lee NH; Park WJ; Ahn JC; Won KH; Uk Lee S; Cho JH; Kim SK; Ahn T; Hong S; Yoo SY; Kim SY; Kim BS; Juhn JH; Kim SY; Lee YJ; Oh BH
    Clin Ther; 2015 Aug; 37(8):1726-39. PubMed ID: 26164786
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.